Activation of cellular immune responses using a dengue tetravalent subunit DNA vaccine candidate with different cytokines as adjuvants
Dengue remains a critical public health issue in endemic areas, with four co-circulating serotypes (DENV-1–4) and no widely accessible vaccine in Brazil. DNA vaccines offer logistical and cost advantages, and cytokine adjuvants may enhance immunogenicity. We engineered a tetravalent DNA vaccine enco...
Saved in:
| Main Authors: | Luciana de Souza Fernandes, Carine Ribeiro Pessoa, Roberto Sousa Dias, Cynthia Canedo da Silva, Sérgio Oliveira de Paula |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-10-01
|
| Series: | Vaccine: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136225000993 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TAK-003: development of a tetravalent dengue vaccine
by: Xavier Sáez-Llorens, et al.
Published: (2025-12-01) -
Assessment of the Adjuvant Effects of Lentinan on the Tuberculosis Subunit Vaccine BG
by: Shuai Zhou, et al.
Published: (2025-05-01) -
A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination
by: Roberto Dias de Oliveira, et al.
Published: (2024-11-01) -
Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive)
by: Viktor V. Romanenko, et al.
Published: (2024-07-01) -
The Immunogenicity and Safety of CYD-Tetravalent Dengue Vaccine (CYD-TDV) in Children and Adolescents: A Systematic Review
by: Raksheeth Agarwal, et al.
Published: (2017-05-01)